Good news! Yaohai Bio-Pharma has recently passed the on-site audit by the European Union Qualified Person (QP) for the GMP quality system and production site. Additionally, it has cleared the initial
Yaohaibio Sterile PreparationsService AbilityIn March 2022 the new production line of Yaohaibio macromolecular drug R&D and production service was put into operation, including a new sterile produ
Frost & Sullivan (Frost & Sullivan, abbreviated as “Sullivan”) officially issued the Research Report on the Development Status and Future Trends of CDMO Industry (hereinafter referred to as th